Keyphrases
Growth Inhibition
100%
Rapamycin
100%
Human Lymphocytes
100%
Cyclin D3
100%
Target of Rapamycin
100%
Mediated Growth
100%
P27Kip1
60%
T Cells
40%
Interleukin-2
40%
Primary T Cells
40%
Mechanism of Action
20%
Knock-in Mouse Model
20%
Cell Growth
20%
Lymphocytes
20%
Phase II Clinical Trial
20%
Ionomycin
20%
Immunosuppressive Activity
20%
Cyclin-dependent Kinase Inhibitor
20%
G1-S Transition
20%
Rapamycin Treatment
20%
Mitogen Stimulation
20%
Biochemistry, Genetics and Molecular Biology
Lymphocyte
100%
Growth Inhibition
100%
T Cell
100%
Cyclin D3
100%
Knockout Mouse
25%
Cyclin-Dependent Kinase
25%
Cell Growth
25%
Cell Cycle
25%
Clinical Trial
25%
Downregulation
25%
G1/S Transition
25%
Immunology and Microbiology
Lymphocyte
100%
Growth Inhibition
100%
Cyclin D3
100%
Sirolimus
100%
T Cell
50%
Immunosuppressive Drug
25%
Mitogen
12%
Knockout Mouse
12%
Cell Growth
12%
Downregulation
12%
Cell Cycle
12%
Cycline
12%
Immunosuppressant
12%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Cyclin D3
100%
Immunosuppressive Agent
25%
Clinical Trial
12%
Knockout Mouse
12%
Mitogenic Agent
12%
Ionomycin
12%
Cyclin Dependent Kinase Inhibitor
12%